GLAXOSMITHKLINE FDA Approval ANDA 083951

ANDA 083951

GLAXOSMITHKLINE

FDA Drug Application

Application #083951

Application Sponsors

ANDA 083951GLAXOSMITHKLINE

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL300MG;30MG0EMPRACET W/ CODEINE PHOSPHATE #3ACETAMINOPHEN; CODEINE PHOSPHATE
002TABLET;ORAL300MG;60MG0EMPRACET W/ CODEINE PHOSPHATE #4ACETAMINOPHEN; CODEINE PHOSPHATE

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 83951
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMPRACET W\/ CODEINE PHOSPHATE #3","activeIngredients":"ACETAMINOPHEN; CODEINE PHOSPHATE","strength":"300MG;30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"EMPRACET W\/ CODEINE PHOSPHATE #4","activeIngredients":"ACETAMINOPHEN; CODEINE PHOSPHATE","strength":"300MG;60MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"EMPRACET W\/ CODEINE PHOSPHATE #3","submission":"ACETAMINOPHEN; CODEINE PHOSPHATE","actionType":"300MG;30MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"EMPRACET W\/ CODEINE PHOSPHATE #4","submission":"ACETAMINOPHEN; CODEINE PHOSPHATE","actionType":"300MG;60MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.